- Material Characterization,
- Cytotoxicity,
- Hemocompatibility,
- Implantation Testing,
- Intracutaneous Reactivity,
- Sensitization,
- Systemic Toxicity,
- Pyrogenecity, and
- USP Plastics
The global biocompatibility testing services market size valued x billion in 2020 and expected to reach USD x billion by 2027, at a CAGR of x% during the forecast period 2020-2027. Due to increase in the research for the discovery of various types of medical devices. Moreover, due to the prevalence of various life threatening diseases, various new drugs and new devises are coming into the market those new products or devices need to be compatible with the human body, plastics and other polymers intended for use in medical devices, implants or other systems associated with a medical process, must be shown to be compatible with the human body these are the major factors that are driving the growth of the global biocompatibility testing services market over the forecast timeframe.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increase in the prevalence of various diseases such as cardiovascular diseases is a key factor drive the global biocompatibility testing services market. According to World Health Organization, approximately 17.9 Mn death occurred due to cardiovascular diseases around the globe represents 31% of deaths around the globe and many people in developed countries are using heart stents and other medical devices to extend their lives for few more years. Moreover, these medical devices which are implanted in the human body must be biocompatible and the material that they use to make these devices like plastics, polymers also need to be biocompatible otherwise serious adverse effects may occur which may cause in death of the patient so biocompatibility testing should be performed and the raise in funding for the R&D activities by public and private sectors are anticipated to propel the global biocompatibility testing services market over the forecast years.
North America accounted for larger revenue share in global biocompatibility testing services market with significant CAGR. Increase in prevalence of various diseases, rise in R&D activities for the development of new drugs, polymers, plastics and new medical devices, and stringent regulatory guidelines are anticipated to drive the market. Asia pacific biocompatibility testing services market projected to grow at significant rate owing to increase in R&D procedures regarding biocompatibility testing services, rise in government funding for healthcare services, adoption of advanced testing services and increase in healthcare expenditure are expected to enhance the market.
Latin America
Europe
Asia Pacific
Middle East
North America
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.